Literature DB >> 11369378

Posterior synechia of the iris after combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation.

K Shinoda1, A O'hira, S Ishida, M Hoshide, L S Ogawa, Y Ozawa, K Nagasaki, M Inoue, H Katsura.   

Abstract

PURPOSE: Combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation has become a widely accepted treatment for cataracts in patients with vitreoretinal diseases. We examined factors influencing the development of posterior synechia after this triple procedure.
METHODS: One hundred and three patients (107 eyes) were evaluated. The frequency of postoperative posterior synechia, the preoperative diagnosis, whether gas tamponade was used, and the type of lens implanted were reviewed.
RESULTS: Twenty-one eyes (19.6%) developed posterior synechia, and the highest rate (12/39 eyes, 30.8%) was in patients with proliferative diabetic retinopathy. Posterior synechia was more frequent after gas tamponade (28.1%) than in eyes without tamponade (10.1%). In proliferative diabetic retinopathy (PDR) patients, fibrin deposition and the amount of retinal photocoagulation were causative factors for posterior synechia.
CONCLUSIONS: Factors promoting postoperative synechia after the triple procedure included (1) the existence of PDR, (2) expanding gas tamponade, (3) fibrin deposition in PDR, and (4) the amount of photocoagulation in PDR.

Entities:  

Mesh:

Year:  2001        PMID: 11369378     DOI: 10.1016/s0021-5155(01)00319-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  13 in total

1.  Presbyopic phacovitrectomy.

Authors:  R Ling; P Simcock; J McCoombes; S Shaw
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 2.  Surgical treatment of diabetic retinopathy.

Authors:  Horst Helbig; Florian K P Sutter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08       Impact factor: 3.117

3.  Secondary angle-closure glaucoma due to posterior synechiae formation following phacovitrectomy.

Authors:  Osama Makhzoum; Niall James Crosby; Mark Hero
Journal:  Int Ophthalmol       Date:  2011-11-29       Impact factor: 2.031

4.  Change in anterior chamber depth following combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation using different types of intraocular lenses.

Authors:  Akira Watanabe; Tomohiro Shibata; Miho Ozaki; Kiichirou Okano; Kenichi Kozaki; Hiroshi Tsuneoka
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

5.  Pars plana vitrectomy, phacoemulsification and intraocular lens implantation. Comparison of clinical complications in a combined versus two-step surgical approach.

Authors:  Felix Treumer; Arnd Bunse; Martin Rudolf; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-03       Impact factor: 3.117

6.  The role of patient age and intraocular gases in cataract progression following vitrectomy for macular holes and epiretinal membranes.

Authors:  John T Thompson
Journal:  Trans Am Ophthalmol Soc       Date:  2003

7.  Risk factors for posterior synechiae of the iris after 23-gauge phacovitrectomy.

Authors:  Jong-Hyun Oh; Jaehoon Na; Seong-Woo Kim; Jaeryung Oh; Kuhl Huh
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

8.  Surgical and Functional Results of Hybrid 25-27-Gauge Vitrectomy Combined with Coaxial 2.2 mm Small Incision Cataract Surgery.

Authors:  Fabian Höhn; Florian Kretz; Mitrofanis Pavlidis
Journal:  J Ophthalmol       Date:  2016-02-04       Impact factor: 1.909

Review 9.  Inflammation and macular oedema after pars plana vitrectomy.

Authors:  Vito Romano; Martina Angi; Fabrizio Scotti; Renata del Grosso; Davide Romano; Francesco Semeraro; Paolo Vinciguerra; Ciro Costagliola; Mario R Romano
Journal:  Mediators Inflamm       Date:  2013-10-30       Impact factor: 4.711

10.  Anatomical success rate of pars plana vitrectomy for treatment of complex rhegmatogenous retinal detachment.

Authors:  Xhevat Lumi; Zala Lužnik; Goran Petrovski; Beáta Éva Petrovski; Marko Hawlina
Journal:  BMC Ophthalmol       Date:  2016-12-09       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.